Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
8
|
888 Holdings PLC
XMUN:C8V
|
GI |
|
A
|
Adocia SA
F:A89
|
FR |
|
Schrodinger Inc
F:43Z
|
US |
Wall St Price Targets
MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for MDGL is 692.38 USD with a low forecast of 547.42 USD and a high forecast of 1 012.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDGL's stock price target?
Price Target
692.38
USD
According to Wall Street analysts, the average 1-year price target for MDGL is 692.38 USD with a low forecast of 547.42 USD and a high forecast of 1 012.2 USD.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Gross Profit over the next 8 years is 26%.
